Related Experiment Video
Updated: Jul 6, 2026

Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding
Published on: June 9, 2017
Constitutively signaling G-protein-coupled receptors and human disease
L Arvanitakis1, E Geras-Raaka, M C Gershengorn
1Molecular Virology Laboratory, Hellenic Pasteur Institute, Athens, Greece.
Abstract:
Dysregulation of G-protein-coupled receptor (GPCR) function has been shown to be associated with a growing number of human diseases. In some diseases, mutation of an endogenous GPCR causes the receptor to lose the ability to bind agonist or signal (;loss of function' mutation), whereas another mutation causes the receptor to be in an active state in the absence of agonist (;gain of function' mutation), leading to ;constitutive signaling activity'. A number of constitutively active GPCRs are tumorigenic in vitro and in animal models, and cause syndromes of hyperfunction and/or tumors in humans. The recent characterization of a constitutively active GPCR in the genome of a disease-associated, human herpesvirus provides a potential novel mechanism for viral tumorigenesis.
Insights
G-protein-coupled receptors (GPCRs) mutations can cause diseases through loss or gain of function. Constitutively active GPCRs, including one found in a human herpesvirus, can drive tumor formation and disease.
Area of Science:
- Molecular Biology
- Cellular Biology
- Oncology
Background:
- G-protein-coupled receptor (GPCR) dysregulation is linked to numerous human diseases.
- Mutations in GPCRs can lead to loss of function or gain of function, resulting in constitutive signaling activity.
- Constitutively active GPCRs are implicated in tumorigenesis and hyperfunction syndromes.
Purpose of the Study:
- To investigate the role of constitutively active GPCRs in human diseases.
- To explore the potential mechanism of viral tumorigenesis mediated by GPCRs.
Main Methods:
- Analysis of GPCR mutations and their functional consequences.
- In vitro and animal model studies of constitutively active GPCRs.
- Genomic characterization of GPCRs in disease-associated viruses.
Main Results:
- Identified GPCRs with loss of function and gain of function mutations.
- Demonstrated that constitutively active GPCRs can be tumorigenic.
- Characterized a constitutively active GPCR within a human herpesvirus genome.
Conclusions:
- GPCR dysregulation, particularly constitutive signaling, is a significant factor in human disease pathogenesis.
- Constitutively active GPCRs represent a novel mechanism for viral-induced tumorigenesis.
More Related Videos
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
06:56A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4
Published on: March 10, 2018
Related Concept Videos
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
G-protein Coupled Receptors
G-protein Coupled Receptors
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical, 7TM, or...
Activation and Inactivation of G Proteins